Michel Beauverd

Summary

Affiliation: Centre Hospitalier Universitaire Vaudois
Country: Switzerland

Publications

  1. doi request reprint Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
    Michel Beauverd
    Service de Soins Palliatifs, CentreHospitalierUniversitaire Vaudois CHUV, Lausanne, Switzerland
    Cochrane Database Syst Rev 11:CD002064. 2012

Detail Information

Publications1

  1. doi request reprint Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
    Michel Beauverd
    Service de Soins Palliatifs, CentreHospitalierUniversitaire Vaudois CHUV, Lausanne, Switzerland
    Cochrane Database Syst Rev 11:CD002064. 2012
    ..Recombinant human insulin-like growth factor I (rhIGF-I) is a possible disease modifying therapy for amyotrophic lateral sclerosis (ALS, which is also known as motor neuron disease (MND))...